LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | XMD11-85h | 0.37 | uM | LJP6 | 72 | hr | 962 | 10650 | 10692 | 0.9961 | 0.9977 |
MCF 10A | XMD11-85h | 1.11 | uM | LJP6 | 72 | hr | 962 | 10543 | 10692 | 0.9861 | 0.9919 |
MCF 10A | XMD11-85h | 3.33 | uM | LJP6 | 72 | hr | 962 | 10124 | 10692 | 0.9470 | 0.9689 |
MCF 10A | XMD11-85h | 10 | uM | LJP6 | 72 | hr | 962 | 6201 | 10692 | 0.5800 | 0.7096 |
MCF 10A | XMD16-144 | 0.04 | uM | LJP5 | 72 | hr | 962 | 2697 | 10512 | 0.2566 | 0.3474 |
MCF 10A | XMD16-144 | 0.12 | uM | LJP5 | 72 | hr | 962 | 1452 | 10512 | 0.1382 | 0.1267 |
MCF 10A | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 962 | 1603 | 10512 | 0.1526 | 0.1594 |
MCF 10A | XMD16-144 | 1.11 | uM | LJP5 | 72 | hr | 962 | 1438 | 10512 | 0.1369 | 0.1236 |
MCF 10A | XMD16-144 | 3.33 | uM | LJP5 | 72 | hr | 962 | 1265 | 10512 | 0.1204 | 0.0824 |
MCF 10A | XMD16-144 | 10 | uM | LJP5 | 72 | hr | 962 | 979 | 10512 | 0.0932 | 0.0040 |
MCF 10A | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 9767 | 10512 | 0.9292 | 0.9579 |
MCF 10A | Erlotinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 5630 | 10512 | 0.5359 | 0.6690 |
MCF 10A | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 2213 | 10512 | 0.2107 | 0.2731 |
MCF 10A | Erlotinib | 1.11 | uM | LJP5 | 72 | hr | 962 | 1460 | 10512 | 0.1390 | 0.1284 |
MCF 10A | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1534 | 10512 | 0.1460 | 0.1446 |
MCF 10A | Erlotinib | 10 | uM | LJP5 | 72 | hr | 962 | 1501 | 10512 | 0.1429 | 0.1375 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 962 | 9196 | 10692 | 0.8601 | 0.9151 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 5221 | 10692 | 0.4883 | 0.6271 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 2267 | 10692 | 0.2120 | 0.2795 |
MCF 10A | Gefitinib | 1.11 | uM | LJP6 | 72 | hr | 962 | 1470 | 10692 | 0.1375 | 0.1297 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 1402 | 10692 | 0.1311 | 0.1143 |
MCF 10A | Gefitinib | 10 | uM | LJP6 | 72 | hr | 962 | 1262 | 10692 | 0.1181 | 0.0803 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 9781 | 10512 | 0.9306 | 0.9587 |
MCF 10A | Nilotinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 9650 | 10512 | 0.9180 | 0.9508 |
MCF 10A | Nilotinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 9569 | 10512 | 0.9101 | 0.9460 |